Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Chembiochem : a European Journal of Chemical Biology|March 5, 2004
Copper binding to the neurotoxic peptide PrP106-126: thermodynamic and structural studiesBarbara Belosi, Elena Gaggelli, Remo Guerrini, et al.The Journal of Physical Chemistry. B|December 13, 2007
NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environmentElena Gaggelli, Anna Janicka-Klos, Elzbieta Jankowska, et al.Dalton Transactions (Cambridge, England : 2003)|September 10, 2004
Identification of a novel high affinity copper binding site in the APP(145-155) fragment of amyloid precursor proteinDaniela Valensin, Francesca Maria Mancini, Marek Łuczkowski, et al.Molecular Biosystems|April 22, 2009
Copper(II) coordination outside the tandem repeat region of an unstructured domain of chicken prion proteinEwa Gralka, Daniela Valensin, Karolina Gajda, et al.Journal of Inorganic Biochemistry|October 22, 2020
Zn(II)-alloferon complexes - Similar sequence, different coordination modes, no antibacterial activityDorota Dudek, Adriana Miller, Sara Draghi, et al.Inorganic Chemistry|August 15, 2023
Semenogelins Armed in Zn(II) and Cu(II): May Bioinorganic Chemistry Help Nature to Cope with Enterococcus faecalis?Dorota Dudek, Adriana Miller, Aleksandra Hecel, et al.Inorganic Chemistry|July 10, 2009
Heteronuclear and homonuclear Cu2+ and Zn2+ complexes with multihistidine peptides based on zebrafish prion-like proteinDaniela Valensin, Łukasz Szyrwiel, Francesca Camponeschi, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 8, 2019
Chemically stable inhibitors of 14-3-3 protein-protein interactions derived from BV02Leire Iralde-Lorente, Ylenia Cau, Letizia Clementi, et al.Inorganic Chemistry|August 2, 2019
Fibrils of α-Synuclein Abolish the Affinity of Cu2+-Binding Site to His50 and Induce Hopping of Cu2+ Ions in the TerminiDaniel N Bloch, Paulina Kolkowska, Isabella Tessari, et al.Inorganic Chemistry|May 13, 2010
fac-{Ru(CO)(3)}(2+) selectively targets the histidine residues of the beta-amyloid peptide 1-28. Implications for new Alzheimer's disease treatments based on ruthenium complexesDaniela Valensin, Paolo Anzini, Elena Gaggelli, et al.Pageof 10